Equities

BTC Health Ltd

BTC:ASX

BTC Health Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.041
  • Today's Change-0.005 / -10.87%
  • Shares traded24.48k
  • 1 Year change+115.79%
  • Beta0.7316
Data delayed at least 20 minutes, as of Jun 07 2024 03:29 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BTC health Ltd is an Australia-based pooled development fund which makes active investments in businesses that acquire, develop and distribute medical products in Australia and New Zealand. The Company is building a group of businesses which together are focused on providing access to specialized therapeutics and medical devices from around the world. It has direct interests in three investee companies: BTC Specialty Health Pty Limited (BTC Specialty Health), BTC Pharma Pty Limited (BTC Pharma) and BTC Cardio Pty Limited (BTC Cardio). BTC Speciality Health is an established distributor of medical devices, consumables, and specialty pharmaceuticals in the Australian and New Zealand public and private hospital markets. BTC Pharma is engaged in the business of licensing and/or acquiring the rights to specialized pharmaceutical products. BTC Cardio is engaged in the business of building a diversified portfolio of highly specialized cardiology, cardio thoracic and critical care products.

  • Revenue in AUD (TTM)16.03k
  • Net income in AUD-8.26m
  • Incorporated2000
  • Employees1.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tissue Repair Ltd457.52k-3.28m13.30m----0.7724--29.07-0.0542-0.05420.00760.28480.0209--7.95---14.96---15.46--98.19---716.30--25.84--0.00------38.95------
Nyrada Inc3.08m-4.98m13.46m----2.56--4.37-0.0319-0.03190.01980.02940.3983-------64.37-64.90-71.93-84.66-----161.62-380.62---15,086.390.00--42.54229.09-96.52------
Radiopharm Theranostics Ltd0.00-46.82m13.81m----0.4601-----0.1343-0.13430.000.06520.00-------63.11---77.85-------------7.480.00-------13.78------
Patrys Ltd1.70m-5.12m14.40m15.00--2.87--8.50-0.0025-0.00250.00080.00240.1978--0.5828---59.77-43.96-68.99-47.06-----302.26-230.44----0.00---14.4540.52-4.15------
Adalta Ltd3.56m-5.04m14.44m----5.86--4.05-0.0129-0.01290.00920.00460.5491--4.72---77.76-67.77-195.09-103.16-----141.60-160.72---57.860.4533--28.1811.1719.96---7.47--
Argent BioPharma Ltd1.32m-17.02m14.49m----8.61--10.94-3.32-3.320.10030.03720.08130.70781.58---105.32-111.29-345.98-171.0521.8732.52-1,295.20-632.420.6561-24.850.4104---28.4147.31-2.34---16.20--
Chimeric Therapeutics Ltd0.00-11.31m14.67m----0.8901-----0.027-0.0270.000.01910.00-------45.96---69.36-------------10.010.1596-------60.40------
Medlab Clinical Ltd366.64k-3.94m15.07m14.00------41.11-1.73-1.730.1606-0.30680.1069--5.82---103.72-55.07-240.52-69.7584.7752.86-970.74-335.43---342.19-----28.90-29.8318.55---30.00--
Lumos Diagnostics Holdings Ltd12.36m-13.28m15.88m----1.14--1.28-0.0357-0.03570.03510.02890.34182.246.37---36.70-40.15-55.14-56.6759.7345.97-107.38-162.900.479-6.250.4803---9.4239.2980.38---38.50--
BTC Health Ltd16.03k-8.26m16.53m1.00--3.0510.011,031.21-0.0305-0.03050.000050.01670.0017--0.031---89.67-23.15-91.36-24.64-----51,522.02-2,498.18---0.07870.00---86.04-26.76-1,665.01------
Oncosil Medical Ltd355.30k-11.71m16.66m2.00--2.56--46.89-0.0081-0.00810.00020.0020.0506--7.88---166.55-57.65-234.81-64.83-426.96---3,295.08-473.02---68.930.0256---59.92-37.72-5.74--40.13--
Auscann Group Holdings Ltd2.05m-9.44m17.73m27.00------8.65-0.0213-0.02170.00430.01620.1674--5.35---77.15-39.85-78.72-40.73100.59---460.74-925.91---23.160.00--13.8851.3757.10------
Rhythm Biosciences Ltd157.67k-8.63m17.90m----13.08--113.52-0.0386-0.03860.00070.00550.0263--1.81---144.00-106.11-169.71-125.51-1,899.74-1,210.71-5,473.20-6,642.262.04--0.0304--814.1828.776.55---20.43--
Algorae Pharmaceuticals Ltd84.10k-2.25m18.56m----5.12--220.71-0.0015-0.00150.000060.00220.0245--1.79---65.51-46.12-70.91-53.52-----2,678.04-591.05---136.750.00--1,132.26-44.06-7.68------
LBT Innovations Limited2.00m-21.38m18.77m17.00--6.91--9.37-0.0428-0.04280.00380.0020.10870.08192.25117,882.40-115.89-28.85-131.86-30.9994.76---1,066.62-441.763.30-6.850.5633---5.29-18.45-239.17---34.63--
Amplia Therapeutics Ltd4.44m-4.50m19.01m1.00--1.22--4.28-0.0226-0.02260.02220.05720.2647--2.05---26.86-25.13-32.90-27.42-----101.48-206.74----0.122--286.42144.8127.86---6.91--
Data as of Jun 07 2024. Currency figures normalised to BTC Health Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.